ABIGAIL ROULSTON: Open Payments
NPI 1386341121 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 48 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $470 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $279 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Abbott Laboratories | 4 | $92 |
| Lilly USA, LLC | 3 | $69 |
| Stryker Corporation | 2 | $51 |
| Dynavax Technologies Corporation | 2 | $51 |
| ABBVIE INC. | 3 | $51 |
| PFIZER INC. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Zimmer Biomet Holdings, Inc. | 1 | $40 |
Products named: Ozempic, FREESTYLE LIBRE 3, Wegovy, AIRSUPRA, Heplisav-B, JARDIANCE, PREVNAR 20, XIFAXAN.
Industry payments across SC — which companies pay providers there.
